technetium tc 99m sestamibi has been researched along with Carcinoma, Oat Cell in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 15 (65.22) | 18.2507 |
| 2000's | 8 (34.78) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Changlai, SP; Ding, HJ; Hsu, WH; Huang, WT; Kao, A; Tsai, CS | 1 |
| Akgun, A; Burak, Z; Cok, G; Goksel, T; Karapolat, I | 1 |
| Boaziz, C; Caglar, M; Caillat-Vigneron, N; Morere, JF; Moretti, JL | 1 |
| Bom, HS; Choi, IS; Kim, JY; Kim, YC; Park, KO | 1 |
| Müller, SP; Paas, M; Reiners, C | 1 |
| Hsu, CY; Kao, CH; Liao, SQ; Lin, WY; Wang, SJ; Yeh, SH | 1 |
| Kawasaki, Y; Nishiyama, Y; Ohkawa, M; Satoh, K; Takashima, H; Tanabe, M; Yamamoto, Y | 1 |
| DeSimone, P; Shih, WJ; Stipp, V; Turturro, F | 1 |
| Baltalï, E; Bekdik, CF; Elahi, N; Hayran, M; Kïratlï, P; Kostakoglu, L; Ruacan, S; Sayek, I; Sungur, A | 1 |
| Bandera, M; Beghe, B; Ceriani, L; Giovanella, L; Ortelli, M; Roncari, G | 1 |
| Bom, HS; Kim, JY; Kim, YC; Min, JJ; Park, KO; Song, HC | 1 |
| Bekdik, CF; Emri, S; Ergün, EL; Hayran, M; Kiratli, P; Kostakoglu, L; Ruacan, S | 1 |
| ChangLai, SP; Chieng, PU; Kao, CH; Yen, TC | 1 |
| Fujita, J; Kishi, T; Matsuno, S; Nishiyama, Y; Ohkawa, M; Satoh, K; Takashima, H; Tanabe, M; Yamamoto, Y | 1 |
| Bom, HS; Jeong, HJ; Kim, JY; Kim, YC; Lee, J; Lim, SC; Min, JJ; Park, KO; Song, HC | 1 |
| Arai, T; Araki, T; Arbab, AS; Koizumi, K; Toyama, K | 1 |
| Benazzouz, F; Cordobes, MD; de Beco, V; Moretti, JL; Starzec, A | 1 |
| Bom, HS; Kim, YC; Lim, SC; Na, KJ; Park, KO; Song, H | 1 |
| Aratani, T; Komori, T; Matsui, R; Narabayashi, I; Sueyoshi, K; Utsunomiya, K | 1 |
| Berkarda, S; Cakir, E; Cermik, TF; Gültekin, A; Karlikaya, C; Salan, A; Yüksel, M | 1 |
| Fujita, J; Fukunaga, K; Nishiyama, Y; Ohkawa, M; Satoh, K; Yamamoto, Y | 1 |
| Hsu, NY; Kao, A; Lee, CC; Lin, CC; Shiun, SC; Sun, SS | 1 |
| Burak, Z; Dirlik, A; Erinc, R; Goksel, T; Karakus, H; Ozcan, Z; Ozhan, M; Veral, A | 1 |
4 trial(s) available for technetium tc 99m sestamibi and Carcinoma, Oat Cell
| Article | Year |
|---|---|
Tc-99m MIBI SPECT in prediction of prognosis in patients with small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Outcome Assessment, Health Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis; Survival Rate; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Turkey | 2006 |
[ROC analysis of tumor identification using 201Tl-(I)-chloride and 99mTc-(I)-hexakis (2-methoxy-2-isobutylisonitrile].
Topics: Adenocarcinoma; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Humans; Male; Prospective Studies; ROC Curve; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1994 |
Dipyridamole modulated Tc-99m sestamibi lung SPECT in small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Cisplatin; Dipyridamole; Drug Resistance, Multiple; Etoposide; Female; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1999 |
Comparison of Tc-99m sestamibi, serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy in small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Small Cell; Dipyridamole; Female; Humans; L-Lactate Dehydrogenase; Lung Neoplasms; Male; Middle Aged; Phosphopyruvate Hydratase; Predictive Value of Tests; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2000 |
19 other study(ies) available for technetium tc 99m sestamibi and Carcinoma, Oat Cell
| Article | Year |
|---|---|
Using technetium-99m methoxyisobutylisonitrile lung single-photon-emission computed tomography to predict response to chemotherapy and compare with P-glycoprotein expression in patients with untreated small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2003 |
Sequential functional imaging with technetium-99m hexakis-2-methoxyisobutylisonitrile and indium-111 octreotide: can we predict the response to chemotherapy in small cell lung cancer?
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Drug Resistance, Multiple; Humans; Indium Radioisotopes; Lung; Lung Neoplasms; Male; Middle Aged; Octreotide; Prognosis; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Treatment Failure | 1995 |
Tc-99m MIBI uptake in simultaneous thyroid and lung cancers.
Topics: Adenocarcinoma, Follicular; Carcinoma, Small Cell; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Thyroid Neoplasms | 1994 |
Differentiation of single solid lesions in the lungs by means of single-photon emission tomography with technetium-99m methoxyisobutylisonitrile.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Humans; Lung; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1993 |
[Evaluation of 99mTc-MIBI to predict chemotherapeutic response in patients with small cell lung carcinoma].
Topics: Adult; Aged; Carcinoma, Small Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1996 |
Ring appearance of Tc-99m MIBI thoracic SPECTs and increased uptake on Tc-99m HMDP thoracic SPECTs in a pulmonary mass of small cell carcinoma.
Topics: Bone Neoplasms; Carcinoma, Small Cell; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Thorax; Tomography, Emission-Computed, Single-Photon | 1996 |
Clinical validation of the influence of P-glycoprotein on technetium-99m-sestamibi uptake in malignant tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Medullary; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Resistance, Multiple; Female; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Neoplasm Proteins; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 1997 |
Semi-quantitative assessment of 99Tcm-sestamibi uptake in lung cancer: relationship with clinical response to chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vindesine | 1997 |
Technetium-99m-MIBI uptake in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Case-Control Studies; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1998 |
Association of tumor washout rates and accumulation of technetium-99m-MIBI with expression of P-glycoprotein in lung cancer.
Topics: Adult; Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Resistance, Neoplasm; Female; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 1998 |
Technetium-99m methoxyisobutylisonitrile chest imaging of small cell lung carcinoma: relation to patient prognosis and chemotherapy response--a preliminary report.
Topics: Aged; Carcinoma, Small Cell; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Technetium Tc 99m Sestamibi; Thorax; Tomography, Emission-Computed, Single-Photon | 1998 |
Comparative study of technetium-99m-sestamibi and thallium-201 SPECT in predicting chemotherapeutic response in small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1998 |
Effects of ion channel modulators in the influx and efflux of Tc-99m-MIBI.
Topics: Adrenal Cortex Neoplasms; Amiloride; Calcium; Calcium Channel Blockers; Calcium Channels; Carcinoma, Small Cell; Flunarizine; Humans; Monensin; Sodium; Sodium Channels; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured; Verapamil | 1999 |
Uptake of liposome-encapsulated 99Tcm-MIBI by sensitive and multidrug-resistant tumour cell lines.
Topics: Adenocarcinoma; Biological Transport; Breast Neoplasms; Carcinoma, Small Cell; Cholesterol; Drug Resistance, Multiple; Female; Humans; Kinetics; Liposomes; Lung Neoplasms; Mouth Neoplasms; Phosphatidylcholines; Phosphatidylethanolamines; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured | 1999 |
Technetium-99m MIBI single photon emission computed tomography as an indicator of prognosis for patients with lung cancer-preliminaly report.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Survival Rate; Technetium Tc 99m Sestamibi; Time Factors; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2000 |
Monitoring the chemotherapeutic response in primary lung cancer using 99mTc-MIBI SPET.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2001 |
99mTc-MIBI SPECT in small cell lung cancer patients before chemotherapy and after unresponsive chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Time Factors; Treatment Failure | 2001 |
Technetium-99m methoxyisobutylisonitrile chest imaging for small-cell lung cancer. Relationship to chemotherapy response (six courses of combination of cisplatin and etoposide) and p-glycoprotein or multidrug resistance related protein expression.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Immunoenzyme Techniques; Lung Neoplasms; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Prognosis; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2001 |
The role of Tc-99m sestamibi imaging in predicting clinical response to chemotherapy in lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2002 |